•  
  •  
 

Document Type

Original Article

Abstract

Background: The laparoscopic Roux-en-Y gastric bypass (LRYGB) is currently suggested as the operation of choice for cases with severe obesity & gastroesophageal reflux disease GERD, since it has been correlated with acceptable GERD control in both short-term and long-term trials. This study aimed to quantify the rate of GERD amongst individuals who underwent laparoscopic sleeve gastrectomy (LSG). Subjects and methods: This was a prospective, randomized, clinical research. This research done on thirty cases with class II obesity with co-morbidities or class III obesity who were candidates to bariatric operation was accepted despite their GERD symptoms. The patients selected from surgery clinic in Al-azhar University Hospitals and al-salaam governmental Hospital. The work was carried out in the period from febraury 2021 to November 2021. Results: we found that 16.7% of pts who have never symptoms of GERD after lap. Sleeve they had errosive esophagitis grade a, 16.7% of pts who have mild symptoms of GERD after lap. Sleeve they had errosive esophagitis grade a, 66.7% of pts who have moderate symptoms of GERD after lap. Sleeve they had errosive esophagitis grade A. Conclusion: Based on these findings, LSG is increasingly being seen as a bariatric procedure for obese individuals who also suffer from GERD.

Keywords

Gastro-esophageal Reflux Disease; Post-Sleeve Surgery; Bariatric

Subject Area

General Surgery

Share

COinS